Congo vs Madagascar: Antiretroviral therapy coverage
Congo
34.0%
in 2024
Madagascar
29.0%
in 2024
Congo rank
135th
Madagascar rank
136th
Antiretroviral therapy coverage over time
- Congo
- Madagascar
How they compare
Congo currently reports 34.0% against 29.0% in Madagascar, a difference of 5.0%.
That makes Congo's figure about 1.2 times Madagascar's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Madagascar ahead.
Congo ranks 135th and Madagascar ranks 136th of 143 countries.
Congo has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Congo | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.7% | 0.4% | 3.3% | Congo |
| 2010s | 19.7% | 3.6% | 16.1% | Congo |
| 2020s | 28.2% | 18.8% | 9.4% | Congo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Congo or Madagascar?
- Congo, at 34.0% against 29.0% in Madagascar as of 2024.
- What is the difference in antiretroviral therapy coverage between Congo and Madagascar?
- 5.0%, with Congo ahead.
- How many years of comparable data are there for Congo and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Congo and Madagascar rank globally for antiretroviral therapy coverage?
- Congo ranks 135th and Madagascar ranks 136th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.